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Abstract
Signaling networks are key regulators of cellular function. Although the concentrations of 
signaling proteins are perturbed in disease states, such as cancer, and are modulated by drug 
therapies, our understanding of how such changes shape the properties of signaling networks is 
limited. Here we couple mass cytometry-based single-cell analysis with overexpression of tagged 
signaling proteins to study the dependence of signaling relationships and dynamics on protein 
node abundance. Focusing on the epidermal growth factor receptor (EGFR) signaling network in 
HEK293T cells, we analyze 20 signaling proteins during a one hour EGF stimulation time course 
using a panel of 35 antibodies. Data analysis with BP-R2, a measure that quantifies complex 
signaling relationships, reveals abundance-dependent network states and identifies novel signaling 
relationships. Further, we show that upstream signaling proteins have abundance-dependent effects 
on downstream signaling dynamics. Our approach elucidates the influence of node abundance on 
signal transduction networks and will further our understanding of signaling in health and disease.
Signaling networks are at the core of cellular information processing and transform external 
signals into cellular responses. Signals are transduced by modulating enzymatic activities 
mainly via protein phosphorylation, and cells implement sophisticated mechanisms, such as 
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feedback loops, pathway crosstalk, and differential enzyme localization, to integrate signals 
and drive cellular processes and physiological outputs. The abundance of individual 
signaling pathway components (nodes) is central to the activity and output of a signaling 
network1. Changes in node abundance are tightly regulated and control biological programs 
such as stem cell differentiation and embryogenesis2. Abundance deregulation of particular 
signaling network nodes via genomic, transcriptional, or post-transcriptional regulatory 
defects3–5 underlies human diseases, the prime example being cancer6. Copy number 
alterations of genes encoding critical proteins7–9, independent of mutations that 
constitutively change enzymatic activity10, drive progression of many cancer types. 
Genomic instability in cancer cells causes abnormally broad distributions of signaling 
protein abundances in a given tumor11, yet the consequences of the protein abundance levels 
on signaling properties is poorly understood limiting our ability to rationally design 
therapies.
The epidermal growth factor receptor (EGFR) signaling network is affected by gene copy 
number alterations that deregulate protein abundances (e.g., of EGFR, HER2, ERK and 
AKT) in a number of cancer types7–9. EGFR signaling controls cell growth, motility, 
survival, differentiation, and metabolism12. Many drugs target the activity of the EGFR 
signaling network13,14. The receptor tyrosine kinase (RTK) function of EGFR is activated 
by its dimerization upon ligand binding. EGFR auto-phosphorylation recruits adaptor 
proteins that typically activate the MAPK/ERK and AKT signaling pathways. The 
MAPK/ERK branch activates the GTPase RAS, which triggers a kinase phosphorylation 
cascade consisting of RAF, MEK, ERK, and p90RSK. The output of the MAPK/ERK 
branch is transcription of genes regulating growth and division15,16. Signal transduction 
through the AKT branch starts by PI3K activation, producing PIP3, which recruits AKT and 
PDK1 to the plasma membrane. PDK1 phosphorylates AKT15,17, which mediates signaling 
through the mTORC1 complex to modulate translation via p70S6K and 4EBP117. Other 
AKT targets are GSK3β, PRAS40, and TSC2. The AKT pathway controls cell survival, 
proliferation, and migration17. STAT proteins and the PKC pathway can also be activated by 
EGFR-mediated signaling18,19. EGFR signaling involves crosstalk and feedback loops both 
internally (e.g., active ERK attenuates upstream RAF or MEK signaling via negative 
feedback)15 and with other signaling pathways (e.g., WNT and TGF-β pathways)20,21.
Classically, two approaches are used to characterize the effect of proteins on signal 
transduction. The first approach analyzes cell populations. Here, western blotting, mass 
spectrometry, RNA-microarrays, and synthetic lethality screens are used to identify 
signaling relationships22–24. Protein-protein interaction analyses are used to determine 
which proteins in a network directly interact23,25. Population-based methods yield a 
comprehensive view of signaling but are difficult to use in analysis of protein abundance 
dependencies due to inherent limitations: Proteins must be expressed at different abundances 
or cells must be sorted to yield a non-continuous abundance titration. Such methods result in 
a large number of samples and cell-to-cell protein abundance variations within each sample 
remain masked. The second approach studies signaling relationships in single cells. Here 
fluorescence microscopy and flow cytometry (FACS) are used with a variety of assays, 
including proximity ligation assay (PLA)26 or fluorescence resonance energy transfer 
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(FRET)27. These approaches allow study of signaling relationships and dynamics through 
time and space; however, only a few signaling nodes can be measured simultaneously.
A recently developed single-cell analysis technology, called mass cytometry, allows for the 
simultaneous measurement of over 40 signaling nodes in single cells using metal-isotope 
tagged antibodies28,29. This capability makes mass cytometry uniquely suited to 
comprehensively query the function of nodes in signaling networks within heterogeneous 
cell populations. Mass cytometry is quantitative and, in combination with mass-tag cellular 
barcoding (MCB), a powerful screening tool28. Algorithms to analyze multiplexed single-
cell mass cytometry data allow quantification of signaling relationships, therefore helping to 
decipher the highly complex network behaviors that operate even in simple biological 
systems30.
Here, we coupled protein overexpression with mass cytometry to measure the effect of 
varying node abundance on the activation state and signaling relationships of an 
unstimulated EGFR signaling network, as well as the signaling dynamics of the network in 
response to EGF stimulation. We exploited the finding that transient protein overexpression 
in a cell population typically produces a continuous abundance range of the target protein 
over four orders of magnitude. We overexpressed 20 central EGFR signaling network 
proteins individually in human embryonic kidney (HEK) 293T cells, sampled during an 
EGF stimulation time course over 60 minutes totaling 360 conditions. An average of 11,000 
cells per condition was analyzed with a panel of 35 antibodies to provide a comprehensive 
single-cell proteomic EGFR network analysis. To identify signaling relationships in this 
dataset, we developed a statistical measure that we call 'binned pseudo R-squared' (BP-R2) 
that recapitulated known signaling relationships and identified relationships that were –to 
the best of our knowledge- not described previously. Thus, our experimental and 
computational approach enables study of how the strength and dynamics of signal 
transduction are tuned by node abundances.
Results
Analyzing continuous protein abundance dependencies
To systematically identify and characterize protein abundance-dependent signaling 
relationships, dynamics, and network activation states, we exploited the variation and large 
dynamic range of protein abundance induced by transient transfection and used mass 
cytometry to quantify the abundance of the transfected protein of interest (POI) in 
conjunction with comprehensive signaling network readouts in single cells. We cloned POIs 
genes into vectors containing a cytomegalovirus (CMV) promoter and a GFP-tag 
sequence31 to transiently overexpress GFP-tagged POIs in HEK293T cells (Fig. 1a). The 
tagged protein abundance was measured by mass cytometry using an anti-GFP antibody 
(Fig. 1a). Ordering the measured cells based on the GFP signal provided a continuous POI 
titration (Fig. 1b). Typically, not all cells were transfected, yielding an internal control for 
every experiment. To measure the single-cell EGFR signaling network states, we designed 
and validated a panel of 35 antibodies that mostly detect phosphorylation sites on signaling 
proteins (Supplementary Tables 1-3). These data were used to determine the abundance 
dependencies of network activation state and signaling dynamics (Fig. 1b).
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To validate our system we confirmed that, first, the GFP tag was reliably detected by mass 
cytometry (Supplementary Fig. 1); second, the GFP tag did not affect the localization and 
activity of the POI (Supplementary Fig. 2, 3, Supplementary Table 4, Supplementary File 1); 
third, POI expression levels were linearly related to GFP abundance, validating GFP as 
readout of the total POI abundance (Supplementary Fig. 4a, c); fourth, POI overexpression 
for 18 hours (i.e., the time point of our experiments) did not alter the underlying network 
structure (Supplementary Fig. 4b, c); fifth, the antibody-based GFP quantification by mass 
cytometry was comparable to FACS (Supplementary Fig. 5); sixth, the cell culture media 
and cell detachment did not alter signaling processing in the EGFR network (Supplementary 
Fig. 6, 7); and, seventh, the levels of the GFP-tagged POIs were stable during the 1-hour 
EGF stimulation time course (Supplementary Fig. 8, Supplementary Video 1). We also 
found that the method is robust and highly reproducible as evidenced by the high 
concordance between the three individual experiment replicates (Supplementary Fig. 9, 
Supplementary File 2).
KRASG12V and MEK1DD abundance effect on signaling
We first studied a well-known signaling circuit: Constitutively active mutants of KRAS and 
MEK1 (KRASG12V and MEK1DD) lead to ERK phosphorylation and activate components 
downstream in the MAPK/ERK pathway. As expected, we found that overexpression of 
KRASG12V-GFP or MEK1DD-GFP increased phosphorylation on Thr202 and Tyr204 of 
ERK1/2 (Fig. 2a). Our approach also elucidated the abundance-dependent effects on these 
signaling relationships: The relationship between KRASG12V-GFP and p-ERK1/2 was bow-
like as high levels of KRASG12V-GFP corresponded to reduced phosphorylation of ERK1/2. 
By contrast, the MEK1DD-GFP abundance relationship with p-ERK1/2 was monotonic as p-
ERK1/2 increased with MEK1DD-GFP expression (Fig. 2a). These results verified the 
oncogenic activation of p-ERK1/2 induced by KRASG12V and MEK1DD.
Next, we analyzed the impact of KRASG12V-GFP and MEK1DD-GFP abundance on all 
measured phosphorylation sites. We divided the measured cells into 10 bins according to the 
GFP signals and plotted the bin medians (Fig. 2b, Supplementary Fig. 9b-e). This analysis 
revealed that the phosphorylation site abundances on ERK1/2 and its direct downstream 
target Ser380 of p90RSK had similar relationships to the abundances of KRASG12V-GFP or 
MEK1DD-GFP. Phosphorylation of AKT on Ser473 and its direct target Ser9 of GSK3β also 
had parallel trends and showed reduced levels when the MAPK/ERK signal peaked, 
suggesting inter-pathway regulation. We also observed increased JNK phosphorylation on 
Thr183/Tyr185 induced by the KRASG12V mutant (Fig. 2b) as reported previously32. This 
shows that our approach recapitulates known signaling relationships and identifies 
abundance-determined signaling responses.
We then systematically evaluated signaling relationships between all pairs of measured 
markers modulated by KRASG12V-GFP or MEK1DD-GFP overexpression. We exploited the 
fact that overexpression of one protein increases signaling (i.e., phosphorylation levels) and 
thus expands the dynamic range of many measured markers (Fig. 2c). This enabled the use 
of correlation analysis to distinguish signaling relationships (high correlation) from 
biological and technical noise (low correlation). For example, overexpression of KRASG12V-
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GFP resulted in an increased Spearman correlation between p-ERK1/2 and p-p90RSK 
compared to control (Fig. 2c), whereas ERK-independent phosphorylation sites, such as 
Tyr551 of BTK/ITK, showed low correlation with p-ERK1/2 levels in both control and 
overexpression conditions (Fig. 2d).
Identifying changes in pairwise Spearman correlations for all measured markers in the 
KRASG12V-GFP and MEK1DD-GFP overexpression data compared to the FLAG-GFP 
control enabled systematic analysis of signaling relationship patterns (Fig. 2e, f). 
Phosphorylation levels of proteins in the MAPK/ERK pathways showed strong increases in 
correlation, and pathway members clustered together (Fig. 2e, f, green squares). We also 
observed that phosphorylations of MAPK/p38 pathway members and STAT proteins (STAT1 
and STAT5) were increasingly correlated with levels of MAPK/ERK pathway members as 
MEKDD-GFP levels increased (Fig. 2f, purple rectangle), indicating crosstalk between 
MAPK and STAT pathways. These results reveal relationships among many measured 
markers and show that increases in correlation reflect pathways and grouped biological 
processes.
Automated analysis of abundance-induced signaling
Spearman correlation analysis can uncover strictly monotonic relationships between 
phosphorylation levels on signaling proteins; however, protein abundance-dependent 
signaling responses can be complex (Fig. 2a, see KRASG12V). We therefore developed a 
density-independent measure termed 'binned pseudo R-squared' (BP-R2) to quantify the 
strengths of relationships between the abundance of a POI and measured phosphorylation 
sites. BP-R2 creates 10 bins across the POI-GFP expression range and calculates the 
relationship strength considering bin medians and the global mean (Supplementary Fig. 10a, 
b, Methods, Supplementary Software). Using the BP-R2 values for all negative controls, a 
cutoff for strong signaling relationships was determined (Supplementary Fig. 10c). 
Benchmarking BP-R2 in identifying strong signaling relationships from the overexpression 
datasets showed that BP-R2 outperformed methods often used for this task30,33 
(Supplementary Fig. 11a, b). The strong relationships identified by BP-R2 were plotted in a 
two-dimensional layout guided by canonical pathways (Fig. 2g, h). The directionality of 
measured signaling relationships was determined by Spearman correlation of the bin 
medians (Supplementary Fig. 10b, Methods). A positive correlation indicates that cells show 
generally increasing marker levels and a negative correlation indicates generally decreasing 
marker levels as POI-GFP levels increase.
Analysis of KRASG12V-GFP and MEK1DD-GFP overexpression versus all measured 
markers using BP-R2 revealed strong, positively correlated relationships of MEKDD-GFP to 
downstream MAPK/ERK pathway nodes. KRASG12V-GFP levels, although also positively 
correlated with MAPK/ERK nodes, exhibited the same, but weaker relationships (Fig. 2a, b, 
g, h). Together, these results suggest that feedback regulation of upstream MAPK nodes 
differs between the studied mutants. Additionally, this network view revealed that MEK1DD-
GFP abundance had a strong positive impact on nodes in the MAPK/p38 pathway; the 
previously observed KRASG12V-induced phosphorylation of JNK32 was dependent on 
KRASG12V abundance (Fig. 2g, h). These results show that overexpression of signaling 
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proteins, in conjunction with BP-R2 and correlation analysis, identifies known relationships 
and is a valid platform for discovery of signaling relationships in a comprehensive and 
abundance-dependent manner.
Node abundance dependency analyses of the EGFR network
To study the node abundance dependency of signaling relationships and dynamics in the 
EGFR signaling network, we overexpressed 20 EGFR-related signaling proteins individually 
in HEK293T cells (Table 1). Each of the 20 GFP-tagged POIs was validated in previous 
studies (Supplementary Table 5) and in our system (Supplementary Fig. 2, 3, Supplementary 
File 1). 18 hours after transfection, we treated cells with EGF and quantified signaling by 
mass cytometry over a 60-min time course. To exclude signaling relationships caused by 
channel-to-channel spillover, we applied a stringent experimental filter (Supplementary Fig. 
12, Methods). The median marker intensities during the time course are shown in 
Supplementary Fig. 13a. Based on these data we performed two sets of analyses. In the first, 
we used BP-R2 analysis and Spearman correlations to evaluate how the abundance of 
overexpressed proteins influenced phosphorylation at the measured sites (Fig. 3, 
Supplementary Fig. 13b and Supplementary Files 2-4). In the second, we examined how 
features of signaling dynamics depend on protein abundance (Fig. 4).
In the first analysis, strong and broad signaling responses to overexpression were identified 
for the upstream kinases PDK1-, GSK3β-, SRC-, and ASK1-GFP without EGF stimulation 
(Fig. 3. Overall, we identified 59 strong signaling relationships in the unstimulated 
conditions. Overexpression of many kinases induced strong and positively correlated 
signaling relationships with their own phosphorylation (Fig. 3, Supplementary File 4). 
Overexpression of CRAF-, KRAS-, p70S6K-GFP, and others only induced signaling 
responses upon EGF stimulation (Fig. 3). Notably, under stimulated conditions, KRAS-, 
CRAF-, and MEK1-GFP levels negatively correlated with phosphorylation levels of 
downstream kinases p-ERK1/2 and p-p90RSK (Fig. 3). Activating mutations in KRAS and 
CRAF (Fig. 2), but not protein overexpression alone, may activate oncogenic signaling.
To systematically assess signaling relationships identified by BP-R2, we used the literature-
based signaling network, SIGNOR34. For each relationship, we computed the shortest 
signed directed path length according to the SIGNOR network (Supplementary Table 6). We 
found that 76% of the strong relationships identified in the unstimulated conditions had 
paths with a maximum of three steps, highlighting that our approach identifies rather direct 
signaling relationships. Only 14 abundance-dependent relationships with four or more path 
steps were identified. Comparison of our strong signaling relationships with literature 
indicated that many EGF signaling connections that we identified were previously reported. 
We also propose many relationships that have—to our knowledge—not been previously 
reported, for example: p90RSK to PDK1 (Ser241), GSK3β to SHP2 (Tyr580), JNK1 to 
MAPKAPK2 (Thr334), p110α to MKK3 (Ser189), p110α to MKK6 (Ser207), ASK1 to 
PDK1 (Ser241), ASK1 to GSK3β (Ser9), and ASK1 to AMPKα (Thr172) (Table 2).
Phosphorylation levels of many members of the MAPK/ERK pathways showed complex 
relationships (i.e., measured phosphorylation levels varied over the analyzed POI-GFP range 
and the relationships did not fit linear, sigmoidal, or quadratic models) with levels of POI-
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GFPs upon EGF stimulation. These relationships can be explained by abundance-dependent 
modulation of the signaling dynamics in response to EGF. Thus, in the second set of 
analyses we examined how signaling dynamics, as quantified by amplitude and peak-time, 
depended on abundance of an overexpressed protein (Fig. 4). In order to view signaling 
trajectories as functions of protein abundance, we binned the POI-GFP levels into 10 bins 
(Fig. 4a, Supplementary File 2). This allowed tracing the signaling trajectories of cells with 
similar protein overexpression levels (i.e., those in the same bin) over the EGF stimulation 
time course (Fig. 4b, Supplementary File 5). Strong and robust changes in signaling 
amplitudes (Fig. 4c-i) and peak-times (Supplementary Fig. 14) were found. Notably, the 
maximum amplitudes were independent of the overexpression range of a given POI 
(Supplementary Fig. 15).
We found that high CRAF-GFP and KRAS-GFP abundance strongly reduced signaling 
amplitudes of p-ERK1/2 and p-p90RSK (Fig. 4c, d, i), whereas high abundance of MEK1-
GFP strongly reduced amplitudes and delayed peak-times for p-p90RSK (Fig. 4i, 
Supplementary Fig. 14). Overexpression of ERK2-GFP led to complex abundance-
dependent responses of p-p90RSK and p-ERK1/2 after EGF stimulation (Fig. 4e-h). p-
ERK1/2 amplitudes increased and peak-times delayed as a function of ERK2-GFP 
abundance level (Fig. 4g-i, Supplementary Fig. 14). Intermediate abundance levels of ERK2-
GFP also delayed the p-p90RSK peak-times relative to low ERK2-GFP abundance, whereas 
cells with high ERK2-GFP levels exhibited minimal p-p90RSK signaling dynamics (Fig. 4e, 
f, i, Supplementary Fig. 14). Overexpression of p90RSK-GFP modulated the signaling 
amplitude of its potential crosstalk phosphorylation site, Ser241 of PDK1, in an abundance-
dependent manner, and increasing expression of p90RSK increased p-PDK1 amplitudes 
(Fig. 4i). Thus, we observed abundance-dependent signaling dynamics across the range of 
overexpression levels. Overexpression of upstream signaling proteins (KRAS-, CRAF-, 
MEK1-, and ERK2-GFP) in the MAPK/ERK pathway led to reduced signaling amplitudes 
and delayed peak-times of their downstream targets. These observations show that our 
approach can quantify the role of protein abundance in determining the dynamic signaling 
response to an extracellular stimulation.
Discussion
Here we present an approach coupling transient overexpression with mass cytometry-based 
single-cell measurements to characterize signaling network activation states and signaling 
dynamics over a quasi-continuous, high dynamic range of protein abundance. To highlight 
the utility of our approach, we present a comprehensive single-cell proteomic analysis of the 
EGFR network that enabled an analysis of abundance-dependent effects of signaling 
proteins on state and dynamics of the signaling network. We evaluated the effects of 
overexpressing 20 EGFR network key nodes with a 60-minute EGF stimulation time course. 
In each of the 360 conditions, we measured the effect of a POI over a four order of 
magnitude abundance range on 35 markers by mass cytometry providing a unique and 
valuable quantitative single-cell resource of abundance dependencies of EGFR signaling.
Previously, the heterogeneity of protein levels after transient transfection was considered 
problematic. Here, we took advantage of this cell-to-cell variation as it results in a 
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continuous titration of protein abundance over four orders of magnitude. Untransfected cells 
also provided an internal control for each experiment. We used the multiplexing capabilities 
of mass cytometry to characterize abundance dependencies of signaling network state and 
dynamics. Applied to the EGFR signaling network, our approach recapitulated known 
relationships, suggested previously not described ones, and revealed the intricate modulation 
of signal amplitudes and peak-times as functions of continuous protein abundance.
Our approach contributes to the understanding of signaling on several levels. First, the 
approach can be used to study uncharacterized proteins and to suggest additional roles to 
characterized ones. Second, we were able to directly relate POI abundance with the 
comprehensive analysis of signaling dynamics in response to stimulation. Such analyses are 
necessary for understanding of differential signal processing in identical cell types and in 
disease states characterized by heterogeneity in protein expression such as cancer. Third, the 
overexpression yields a large dynamic range of signaling activity and can reveal signaling 
relationships masked by stochastic processes and technical noise under otherwise similar 
conditions, facilitating the computational analysis of signaling relationships. Fourth, we 
present a metric termed BP-R2, which allows the quantification of the strengths of arbitrary 
shaped signaling relationships. BP-R2 was superior to state-of-the-art methods for analysis 
of our dataset. Fifth, and finally, we were able to infer protein abundance-dependent 
signaling kinetics from single-cell snapshot data.
Our approach recapitulated known oncogenic signaling behaviors induced by the 
constitutively active mutants KRASG12V and MEK1DD and identified novel abundance-
dependent signaling relationships. For example, p-ERK1/2 was attenuated in cells with 
highly overexpressed KRASG12V-GFP, potentially due to negative feedback loops or 
senescence35. Overexpression of the wild-type KRAS-GFP and MEK1-GFP did not induce 
downstream signaling activation, suggesting that mutations on KRAS or MEK1 are the main 
drivers of oncogenic signaling. Further, our approach allows study of abundance-dependent 
signaling dynamics. In the MAPK/ERK pathway, high abundance of upstream signaling 
mediators KRAS, CRAF, MEK1, or ERK2 reduced amplitudes and delayed peak-times of 
downstream phosphorylation sites. One possible explanation is that the signal transduction is 
determined by the competition between active and inactive forms of a signaling protein for 
substrates. Overexpression increases the total abundance but may reduce the percentage of 
the active form.
KRAS amplification has been identified in many cancer types. Amplification, however, is 
not correlated with the phosphorylation of ERK1/236. Rather, KRAS amplification mediates 
resistance to inhibitors targeting growth pathway related kinases, including EGFR, MET and 
MEK1/2; KRAS knockdown diminishes the drug resistance37–39. Our results indicate that 
due to reduced downstream signaling amplitudes in response to EGF stimulation, the 
dependency of cells on the MAPK/ERK pathway may decrease upon KRAS overexpression, 
suggesting a mechanism for cancer cell resistance to inhibitors.
Comparing the identified strong signaling relationships with those in the SIGNOR database, 
we propose previously not described signaling relationships, e.g.: 1) Our data suggest that 
p90RSK potentially forms a positive feedback loop and activates the upstream signaling 
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protein PDK1. 2) GSK3β has been identified as a central signaling controller and has 
multiple substrates40; our results suggest that SHP2 is a potential direct or indirect target of 
GSK3β. 3) We also propose that JNK1 is a MAPKAPK2 activator. 4) PI3K and MKK3/6 are 
known to be regulated by RAC141; our results suggest PI3K activates MKK3/6 
independently. 5) Recent studies indicate that ASK1 contributes in negative regulation of 
PDK1 through phosphorylation on Thr254 of PDK142; We observe ASK1 overexpression-
induced PDK1 phosphorylation on Ser241, inducing PDK1 activity and downstream GSK3β 
phosphorylation on Ser9. 6) In addition to the known AMPK-mediated ASK1 activation43, 
our data indicates ASK1 activation of AMPKα via phosphorylation on Thr172. 7) We have 
also observed negative correlations between the abundance of p70S6K or PDK1 to the 
phosphorylation level of S6 (Ser235/Ser236), indicating overexpression-induced-negative 
feedback regulations.
Our method has several limitations. First, we do not measure the endogenous expression 
level of the POI. However, exogenous expression is linearly correlated with the total protein 
level (Supplementary Fig. 4a), validating GFP as readout of the total POI. Second, all results 
in mass cytometry rely on antibodies; for this work, all antibodies were thoroughly validated 
(Supplementary Table 3). Third, we do not measure the abundance range of the studied 
proteins in cancer cells, however, proteome studies of cancer cells and databases such as 
PaxDb11 indicate a range similar to those studied here. Fourth, high expression levels of a 
protein kinase may induce non-specific phosphorylation; however, our data allows choosing 
the analyzed expression range in silico, thus such effects can be excluded.
The approach described here provides a method to study how the abundance variance of 
signaling proteins in different tissues and cell lines results in distinct signaling behaviors. 
The application of our approach to synthetic biology, stem cell biology, developmental 
biology, and cancer-related processes, such as the epithelial-mesenchymal transition, will 
enable quantitative identification of key proteins and signaling determinants in cell 
differentiation at phenotypical switching points. We envision that determining which 
signaling relationships and thresholds enable diseased cells to overcome drug treatment will 
be a highly relevant application.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Workflow of abundance-dependent network analysis. (a) Experimental workflow. Signaling 
POIs are cloned into vectors containing a CMV promoter and a GFP-tag sequence to 
transiently overexpress GFP-tagged POIs in HEK293T cells. We quantify anti-GFP antibody 
as readout of POI-GFP abundance, together with other 35 markers, by mass cytometry. (b) 
Data analysis workflow. Cells were ordered based on the GFP signal, providing a continuous 
POI titration, which was then coupled to other signaling markers to determine the abundance 
Lun et al. Page 13
Nat Biotechnol. Author manuscript; available in PMC 2017 September 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
dependencies of network activation state and signaling dynamics in the network after 
transfection. The network in the illustration does not represent an actual biological example.
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Figure 2. 
MAPK/ERK pathway mutants induce oncogenic signaling. (a) Biaxial plots of GFP, 
representing the abundance of the overexpressed mutant POIs, versus abundance of 
phosphorylation on Thr202/Tyr204 on ERK1/2. Constitutively active KRASG12V-GFP 
shows a downregulation on Thr202/Tyr204 on ERK1/2 at the highest levels of KRASG12V-
GFP. Constitutively active MEK1DD-GFP directly phosphorylates Thr202/Tyr204 on 
ERK1/2, and the abundance of the POI-GFP is correlated with amount of ERK1/2 
phosphorylated at these sites. The FLAG-GFP control does not affect ERK phosphorylation 
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sites. (b) The abundances of measured phosphorylation sites are plotted over the range of the 
KRASG12V-GFP and MEK1DD-GFP expression. Phosphorylation sites of the same pathway 
(e.g., on ERK1/2 and p90RSK, AKT and GSK3β, or p38 and JNK) show similar trends. An 
individual experiment is shown here. Plots for 3 replicates are shown in Supplementary Fig. 
9b-e. (c) Strong single-cell correlations within biaxial plots indicate co-regulated 
phosphorylation sites. (d) Unchanged and reduced correlations indicate unrelated 
phosphorylation sites. (e) and (f) Heat maps showing for all pairs of measured markers the 
change in Fisher-transformed Spearman correlation values for overexpression of (e) 
KRASG12V-GFP and (f) MEK1DD-GFP when compared to the FLAG-GFP overexpression 
control. (g) and (h) BP-R2 scores and Spearman correlations of bin medians for all measured 
markers in cells where (g) KRASG12V-GFP or (h) MEK1DD-GFP was overexpressed 
overlaid on a literature-based graph of canonical signaling 
pathways14,15,21,23,44,45,35,46–48. Strong relationships identified from the BP-R2 
analysis are plotted on the signaling maps as colored circles. The sizes of circles indicate 
relationship strengths quantified by BP-R2. The directionalities of relationships, as judged 
by Spearman correlation of bin medians, are shown by the color of the circles (positive 
correlation indicates that cells show generally increasing marker levels, and a negative 
correlation indicates decreasing marker levels as POI-GFP levels increase). For (e) to (h), 
data from 3 individual experiment replicates were used.
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Figure 3. 
Analysis of dynamics of EGFR signaling. HEK293T cells overexpressing GFP-tagged 
signaling proteins listed in Table 1 were treated with EGF for 0, 5, 15, 30, and 60 min. 
Strong abundance-dependent signaling relationships (Supplementary Fig. 10c) are plotted on 
the signaling map with circle sizes and colors indicating strengths (BP-R2 score) and 
directionalities (Spearman correlation of bin medians), respectively. The miniaturized 
network is the same as used in Fig. 2. Overexpression of S6-GFP did not induce any strong 
Lun et al. Page 17
Nat Biotechnol. Author manuscript; available in PMC 2017 September 27.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
signaling relationships (data not shown). For all analyses, data from 3 individual experiment 
replicates were used.
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Figure 4. 
Analysis of node abundance-dependent EGFR signaling dynamics. (a, b) Schematic plots of 
amplitude and peak-time analysis. (a) The x-axis (i.e., overexpressed protein as determined 
by the GFP measurement) was split into 10 bins. (b) Median phosphorylation abundance in 
each bin was plotted on the y-axis versus time (x-axis) to visualize abundance dependency 
of signaling dynamics. (c, d) Mass cytometry ion counts (arcsinh transformed, Methods) 
measured for p-p90RSK (y-axis) as a function of ion counts measured for abundance of 
CRAF-GFP (x-axis) and EGF stimulation time. The same layouts for (e, f) ERK2-GFP 
abundance-determined p-p90RSK levels and (g, h) p-ERK1/2 levels are shown. (i) Heat map 
showing protein abundances with strong influences on signaling amplitudes with color 
indicating normalized signaling amplitudes. Only overexpressed proteins with an amplitude-
ratio higher than 3 fold for more than two of the three replicates were identified as strong 
influences and are included in the heat map. For (a) to (h), representative examples from the 
3 individual experiment replicates are shown. Other replicates are presented in 
Supplementary File 5. In (i), all replicate data are shown.
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Table 1
Overexpressed signaling proteins
Overexpressed proteins Gene ID UniProt Entry
SRC SRC P12931
PDK1 PDPK1 O15530
AKT1 AKT1 P31749
GSK3β GSK3B P49841
MKK7 MAP2K7 O14733
MKK6 MAP2K6 P52564
p38α MAPK14 Q16539
ERK2 MAPK1 P28482
p90RSK RPS6KA1 Q15418
CRAF RAF1 P04049
JNK1 MAPK8 P45983
p110α PIK3CA P42336
BRAF BRAF P15056
ASK1 MAP3K5 Q99683
p70S6K RPS6KB1 P23443
MEK1 MAP2K1 Q02750
KRAS KRAS P01116
HRAS HRAS P01112
SHP2 PTPN11 Q06124
S6 RPS6 P62753
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Table 2
Relationships with shortest singed directed path length above 3 in the SIGNOR database
Overexpressed POI Target Sign Shortest Signed Directed Path (SIGNOR) Literature Information
SRC p-BTK/ITK 1 6 SRC family kinases phosphorylate BTK48
SHP2 p-S6 -1 5 Known regulation49
ASK1 p-PDK1 1 5 Potential novel relationship
SRC p-PLCγ2 1 5 SRC family kinases activates PLCγ248
ASK1 p-AMPKα 1 4 Potential novel relationship
GSK3β p-SHP2 1 4 Potential novel relationship
p90RSK p-PDK1 1 4 Potential novel relationship
JNK1 p-STAT1 1 4 JNK activates STAT150
JNK1 p-MAPKAPK2 1 4 Potential novel relationship
p110α p-MKK3/6 1 4 Potential novel relationships
HRAS p-SMAD2/3 1 4 Known crosstalk21
ASK1 p-GSK3β 1 4 Potential novel relationships
PDK1 p-S6 -1 4 Overexpression-induced negative regulation
p70S6K p-S6 -1 4 Overexpression-induced negative regulation
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